First Turn Management, LLC Syndax Pharmaceuticals Inc Transaction History
First Turn Management, LLC
- $632 Billion
- Q3 2024
A detailed history of First Turn Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, First Turn Management, LLC holds 1,187,165 shares of SNDX stock, worth $15.2 Million. This represents 3.62% of its overall portfolio holdings.
Number of Shares
1,187,165
Previous 640,389
85.38%
Holding current value
$15.2 Million
Previous $13.1 Billion
73.82%
% of portfolio
3.62%
Previous 2.14%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$101 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$74.6 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$63.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$62.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$52.4 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $722M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...